11 research outputs found
CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1
Full text linkCirculating tumor cells and γH2AX as biomarkers for responsiveness to radium-223 in advanced prostate cancer patients
Full text link
Gastrointestinal Stromal Tumor (GIST) Causing Obscure Gastrointestinal Bleeding: An Uncommon Way of Diagnosing An Uncommon Disease
Full text link
Exploring the endogenous potential of Hemidesmus indicus against breast cancer using in silico studies and quantification of 2-hydroxy-4-methoxy benzaldehyde through RP-HPLC
Full text linkMortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers
Full text linkPatient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Full text link
